FedEx (FDX) is scheduled to release its earnings next week–and RBC’s John Barnes and team aren’t expecting great news:
FedExreports 3FQ/16 (ended February 2016) results on March 16 after market close…We are trimming our 3FQ/16 EPS estimates to reflect higher than expected peak season costs. We also expect the company to rein in FY/16 EPS guidance when it reports. Accordingly, we are cautious onFedEx into earnings next week…
FedExoperations negatively impacted by severe weather and a last minute surge in volumes the week before Christmas. In order to cope, the company ran operations of Christmas and the day after. We believe this reduced Ground margins by 70 bps. Our sense is that this was less of an issue for the Express operation…
Mid-point of guidance likely to move lower. Our new FY/16 EPS estimate of $10.43 sits near the low end of the $10.40-$10.90 guidance range. We expect management to both lower guidance and tighten the range to $10.40-10.60 even after incorporating the benefit from share repurchase activity.
Top 10 Construction Stocks To Watch Right Now: Flextronics International Ltd.(FLEX)
Flextronics International Ltd. provides design and electronics manufacturing services to original equipment manufacturers. The company offers its services to a range of products in the infrastructure, mobile communication devices, computing, consumer digital devices, industrial, semiconductor capital equipment, clean technology, aerospace and defense, white goods, automotive and marine, and medical devices markets. Its services include design and engineering services, such as contract design, joint development manufacturing, and original design and manufacturing services in a range of technical competencies that include system architecture, user interface and industrial design, mechanical engineering, enclosure systems, thermal and tooling design, electronic system design, reliability and failure analysis, and component level development engineering; and systems assembly and manufacturing services, including enclosures, testing, and materials procurement and inventory mana gement services. The company also offers various component product solutions comprising rigid and flexible printed circuit board fabrication, display and touch solutions, optomechatronics, and power supplies; after market supply chain logistics services; and reverse logistics and repair services, such as returns management, exchange programs, complex repair, asset recovery, recycling, and e-waste management services for consumer and midrange products, printers, PDA’s, mobile phones, consumer medical devices, notebooks, PC’s, set-top boxes, game consoles, and infrastructure products. It has operations in Asia, the Americas, and Europe. Flextronics International Ltd. was founded in 1990 and is headquartered in Singapore.
- [By Amber Hestla, Michael J. Carr]
Among its suppliers is Flextronics International (Nasdaq: FLEX), which offers a variety of engineering services and provides supply chain management. Other Flextronics customers include Hewlett-Packard (NYSE: HPQ), LG and Google's (Nasdaq: GOOG) Motorola Mobility.
Top 10 Construction Stocks To Watch Right Now: Ford Motor Company(F)
Ford Motor Company, together with its subsidiaries, designs, manufactures, markets, finances, and services automobiles. The company operates through two sectors, Automotive and Financial Services. The Automotive sector develops, manufactures, distributes, and services passenger cars, trucks, SUVs, light commercial vehicles, trucks, vans, and electrified vehicles, as well as offers parts and accessories. It offers vehicles primarily under the Ford and Lincoln brand names. This sector markets and sells its products through distributors and dealers, as well as through dealerships to fleet customers, including commercial fleet customers, daily rental car companies, and governments. The Financial Services sector offers various automotive financing products to and through automotive dealers. It provides financing products, including retail installment sale contracts for new and used vehicles; and direct financing leases for new vehi cles to retail and commercial customers, government entities, daily rental car companies, leasing companies, and fleet customers. This sector also offers wholesale loans to dealers to finance the purchase of vehicle inventory; and loans to dealers to finance working capital and improvement of dealership facilities, purchase dealership real estate, and other dealer vehicle programs. It serves clients in North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. Ford Motor Company was founded in 1903 and is based in Dearborn, Michigan.
- [By Ben Levisohn]
Shares of Tesla Motors have gained 3.6% to $215.04 at 1:39 p.m. today, while Ford Motor (F) has dipped 0.2% to $13.26, and General Motor (GM) is unchanged at $31.26.
- [By abirk]
Teslas growing valuation now stands at $20.6 billion. This has infused the company with capital to aggressively invest in Superchargers, production, and international expansion. While Tesla has 1 percent of Ford Motor Companys (F) U.S. monthly sales, the electric car company already has nearly a third of Fords $64 billion market capitalization. Tesla is now worth more than Suzuki Motor Co (SZKMF), Mazda Motor Corp (MZDAY), and Fiat, the majority owner of Chrysler Group, according to data compiled by Bloomberg. The stock has almost quadrupled in value this year, so it’s not surprising that most analysts believe the stock is too richly valued to buy at its current levels. With a forecast of 25% for Q4, Tesla has been continually growing its gross profit margins well above, and beyond what Ford and General Motors Company (GM) are capable of.
- [By WALLSTCHEATSHEET.COM]
Ford is a well-established vehicle products and services producer distributed in a multitude of countries across the globe. As the current CEO, Alan Mulally, prepares to leave, Microsoft may be planning on hiring him as its CEO. The stock has been rising higher in recent years and is now trading at highs for the year. Over the past four quarters, investors in the company have expected a little more. However, earnings and revenue figures have been improving. Relative to its peers and sector, Ford has been an year-to-date average performer. Look for Ford Motor to OUTPERFORM.
- [By Chad Fraser]
There are a number of ways for investors to profit from the rising auto sales. The obvious approach is to buy shares of major automakers like General Motors (NYSE: GM), Ford (NYSE: F) or Nissan (OTC: NSANY). (We took a close look at Nissan in a September 3 Investing Daily article. Click here to read the full piece.)
Top 5 Mid Cap Stocks To Buy For 2016: Leading Brands Inc(LBIX)
Leading Brands, Inc., together with its subsidiaries, engages in the development, production, marketing, and distribution of beverages in Canada, the western United States, and Asia. It also involves in beverage bottling, as well as in the sale, merchandising, brand development, brand licensing, and brand management of beverage products. The company?s principal product lines comprise juices and waters. It sells its products under TrueBlue, LiteBlue, and PureBlue brand names, as well as under licensed brand Stewart?s Fountain Classics. The company sells beverage products through its sales force, as well as through outside brokers and agents to retail, wholesale, and distribution outlets. The company was formerly known as Brio Industries Inc. and changed its name to Leading Brands, Inc. in October 1999. Leading Brands, Inc. was founded in 1986 and is headquartered in Vancouver, Canada.
- [By Lisa Levin]
Leading Brands, Inc (USA) (NASDAQ: LBIX) shares shot up 66 percent to $2.49 following Q1 results. Leading Brands reported Q1 earnings of $0.10 per share on revenue of $3.033 million.
Top 10 Construction Stocks To Watch Right Now: BioPharmX Corporation(BPMX)
BioPharmX Corporation, a specialty pharmaceutical company, focuses on the development of novel drug delivery products for women’s health, dermatology, and otolaryngology markets. The company offers prescription, over-the-counter (OTC), and supplement products in oral, topical, inhalant, and/or injectable forms. It provides VI2OLET iodine, an OTC dietary supplement molecular iodine tablet that promotes overall breast health and for the alleviation of benign breast pain associated with fibrocystic breast condition. The companys clinical-stage product candidates include BPX03, a molecular iodine tablet for the treatment of benign breast pain associated with FBC and cyclic mastalgia; and BPX01, a non-lipophilic topical antibiotic for the treatment of acne. It serves pharmaceutical companies; physician’s practices, including OB-Gyn’s, dermatologists, and general practioners; and retail customers through retail sales channels and/ or pharmacy outlets. The company has collaboration and licensing agreement with Iogen LLC for the development of molecular iodine products; and collaboration and supply agreement with NuTech Medical, Inc. to develop products in the field of dermatology. BioPharmX Corporation is headquartered in Menlo Park, California.
- [By Lisa Levin]
Shares of BioPharmX Corp (NYSE: BPMX) were down 31 percent to $1.02 after the company announced the pricing of 3.6 million share common stock.
Puma Biotechnology Inc (NYSE: PBYI) was down, falling around 22 percent to $27.53 after the company issued an update to the timeline for the filing of a new drug application. Puma Biotechnology will submit the NDA for neratinib in mid-2016. According to a press release, the decision was based on the company’s recent meetings with the U.S. Food and Drug Administration.
Top 10 Construction Stocks To Watch Right Now: Christopher & Banks Corporation(CBK)
Christopher & Banks Corporation, through its subsidiaries, operates as a retailer of womens apparel and accessories in the United States. The company designs, sources, and sells womens apparel and accessories to customers ranging in age from 45 to 60. Its stores offer womens apparel consisting of knit tops, woven tops, jackets, sweaters, skirts, denim bottoms, bottoms made of other fabrics, leisure wear, and dresses in missy, petite, and women sizes, as well as jewelry and accessories. As of August 1, 2015, the company operated 529 stores, including 82 Christopher & Banks stores, 73 CJ Banks stores, 309 MPW stores, and 65 outlet stores. It also operates e-commerce Web sites, such as christopherandbanks.com and cjbanks.com. The company was formerly known as Brauns Fashions Corporation and changed its name to Christopher & Banks Corporation in July 2000. Christopher & Banks Corporation was founded in 1956 and is headquar tered in Plymouth, Minnesota.
- [By Lisa Levin]
Christopher & Banks Corporation (NYSE: CBK) shares were also up, gaining 40 percent to $2.64. Christopher & Banks reported a Q4 loss of $0.24 per share on revenue of $94.6 million. The company projects Q1 revenue of $93 million to $98 million.
Top 10 Construction Stocks To Watch Right Now: Becton, Dickinson and Company(BDX)
Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The companys BD Medical segment offers syringes and pen needles for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; generic prefilled injectables; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; prefillable drug delivery systems; respiratory ventilation, and diagnostics equipment and consumables; and consumables for patient monitoring and anesthesia delivery. Its Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing a nd tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and womens health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New ! Jersey.
- [By Ben Levisohn]
Becton Dickinson (BDX) has gained 1.2% to $101.97 this morning afterPiper Jaffrayraised the stock to Overweight from Neutral. AnalystsWilliam Quirk andDavid Clairexplain why they’re optimistic about the medical technology company:
Observations from multiple diagnostic conferences all suggest significant interest inmicrobiology investment. This interest spans track systems (Kiestra), new identificationtechnologies (Maldi/BioTyper) and Molecular (gram +/- assays). When consideringAST (antimicrobial susceptibility testing) recall from Siemens, we believe BD’smicrobiology business is poised to accelerate its performance over the next several years.Combined with a delayed JNJ/Ypsomed pen needle launch and incremental Europeansafety adoption, we believe numbers for BD will continue to climb…
They also raised their price target to $117 from $91.
While Becton has gained today,Johnson & Johnson(JNJ) has dropped 0.6% to $88.50,Medtronic(MDT) has fallen 1%to $53.43,Boston Scientific(BSX) has declined 0.9% to $11.79 and Edwards Lifesciences (EW) is off 1.2% at $70.90.
Top 10 Construction Stocks To Watch Right Now: Corning Incorporated(GLW)
Corning Incorporated manufactures and processes specialty glass and ceramics products worldwide. It operates in five segments: Display Technologies, Telecommunications, Environmental Technologies, Specialty Materials, and Life Sciences. The Display Technologies segment manufactures liquid crystal display (LCD) glass for flat panel displays used primarily in notebook computers, flat panel desktop monitors, and LCD televisions. The Telecommunications segment produces optical fiber and cable, and hardware and equipment products, such as cable assemblies, fiber optic hardware, fiber optic connectors, optical components and couplers, closures and pedestals, splice and test equipment, and other accessories for optical connectivity to the telecommunications industry. This segment also offers optical fiber technology products for various applications, such as premises, fiber-to-the-home access, metropolitan, long-haul, and submarine networks. The Environmental Technologies segment manufactures ceramic substrates and filter products for emissions control in mobile and stationary applications. The Specialty Materials segment manufactures products that provide approximately 150 material formulations for glass, glass ceramics, and fluoride crystals used in commercial and industrial markets. The Life Sciences segment provides scientific laboratory products, such as general labware and equipment, as well as tools for cell culture and bioprocess, genomics and proteomics, and high-throughput screening. This segment also develops and produces various technologies, such as the Corning HYPERFlask Cell Culture Vessel for increased cell yields; and other novel surfaces, which include the Corning CellBIND Surface and the Corning Osteo-Assay surface. The company was formerly known as Corning Glass Works and changed its name to Corning Incorporated in April 1989. Corning Incorporated was founded in 1851 and is based in Corning, New York.
- [By Lisa Levin]
Alliance Fiber Optic Products Inc (NASDAQ: AFOP) shares shot up 19 percent to $18.47 after the company agreed to be acquired by Corning Incorporated (NYSE: GLW) for $18.50 per share.
- [By Dividend]
Here are some of the highest yielding stocks:
Corning (GLW) has a market capitalization of $21.38 billion. The company employs 28,700 people, generates revenue of $8.012 billion and has a net income of $1.728 billion. Cornings earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $2.465 billion. The EBITDA margin is 30.77 percent (the operating margin is 16.16 percent and the net profit margin 21.57 percent).
Top 10 Construction Stocks To Watch Right Now: Ionis Pharmaceuticals, Inc.(IONS)
Ionis Pharmaceuticals, Inc., a RNA-targeted drug discovery and development company, develops drugs for patients with severe and rare diseases in the United States. The company markets KYNAMRO for the treatment of homozygous familial hypercholesterolemia, and Alicaforsen for ulcerative colitis and pouchitis. Its drugs in Phase III development include Nusinersen for the treatment of patients with spinal muscular atrophy; IONIS-TTRRx for the treatment of patients with various forms of TTR amyloidosis, including familial amyloid polyneuropathy, familial amyloid cardiomyopathy, and wild-type TTR amyloidosis; volanesorsen for the treatment of patients with familial chylomicronemia syndrome and familial partial lipodystrophy; Custirsen to treat cancer; and Plazomicin for the treatment of severe bacterial infection. The companys products under development also include IONIS-DMPK-2.5 for myotonic dystrophy type 1; IONIS-HTT for hunti ngton’s disease; ATL1103 for acromegaly; IONIS-SOD1 for amyotrophic lateral sclerosis; IONIS-FXI (BAY 2306001) for clotting disorders; IONIS-APO(a)-L for high Lp; IONIS-ANGPTL3-L for mixed dyslipidemias; Apatorsen (OGX-427) and IONIS-STAT3-2.5 (AZD9150) for cancer; EXC 001 (PF-06473871) for scarring; ATL1102 for multiple sclerosis; RG-101 for hepatitis C virus infection; IONIS-GCGR and IONIS-PTP1B for type 2 diabetes; and IONIS-FGFR4 for obesity. In addition, it is developing IONIS-GCCR for cushing’s syndrome; IONIS-PKK for hereditary angioedema; RG-012 for alport syndrome; IONIS-AR-2.5 (AZD5312) for prostate cancer; IONIS-GSK4-L for ocular disease; IONIS-HBV and IONIS-HBV-L for hepatitis B virus infection; and IONIS-DGAT2 for nonalcoholic steatohepatitis. The company was formerly known as Isis Pharmaceuticals, Inc. and changed its name to Ionis Pharmaceuticals, Inc. in December 2015. Ionis Pharmaceuticals, Inc. was founded in 1989 and is headquartered in Carlsbad, Californi a.
- [By Lisa Levin]
Shares of Ionis Pharmaceuticals Inc (NASDAQ: IONS) were down 40 percent to $21.30 after the company issued an update on the IONIS-TTR program. The company is evaluating IONIS-TTRRx in an ongoing Phase 3 study currently, NEURO-TTR, in patients with transthyretin (TTR) familial amyloid polyneuropathy. According to Ionis, GSK, which has an option to license IONIS-TTRx, has decided not to initiate the stage three outcome study, CARDIO-TTR that was planned to assess IONIS-TTRx in patients with TTR armyloid cardiomyopthy.
Top 10 Construction Stocks To Watch Right Now: TheStreet, Inc.(TST)
TheStreet, Inc., a digital financial media company, provides business and financial news, investing ideas, and analysis to personal and institutional investors worldwide. The company engages in the online publishing of business and investment information through TheStreet, a paid subscription financial news and commentary Website. Its collection of digital services provides various content and tools for users, subscribers, and advertisers through a range of online, social media, tablet, and mobile channels. The companys subscription products include RealMoney, RealMoney Pro, Options Profits, Actions Alerts PLUS, TheStreet Quant Ratings, and Stocks Under $10, which are designed to address the needs of investors with various areas of interest, including fledgling investors, consumers interested in personal finance guidance, long-term and short-term active investors, and day and swing traders, as well as fundamental, technical, and options traders. Its RateWatch business publishes bank rate market information on a subscription basis to financial institutions and government agencies; and product line includes banking-related product and fee comparisons, financial strength reporting, educational webinars, mystery shopping, and consumer and financial institution surveys. In addition, the company operates a digital subscription platform that delivers coverage of the mergers and acquisitions environment primarily through The Deal Pipeline, a transactional information service provider. Further, it is involved in the syndication and licensing of data from TheStreet Ratings, which tracks the risk-adjusted performance of mutual funds and exchange-traded funds, as well as stocks; and operation of advertising-supported properties comprising TheStreet, MainStreet, Stockpickr, and Real Money. TheStreet, Inc. was founded in 1996 and is based in New York, New York.
- [By Steven Goldberg]
Launched in August 2001, Action Alerts PLUS Portfolio has been a centerpiece of the financial advice offered by TheStreet.com. The website belongs to TheStreet, Inc. (TST), a publicly traded company that Cramer co-founded in 1996. PLUS Portfolio subscribers, who pay $15 a month, always get the recommendations before Cramer buys them for the portfolio, the Wharton paper reports. Likewise, subscribers get Cramers picks before he airs them on Mad Money.
Top 10 Construction Stocks To Watch Right Now: Synta Pharmaceuticals Corp.(SNTA)
Synta Pharmaceuticals Corp. focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. Its clinical stage drug candidate in oncology is ganetespib, an Hsp90 inhibitor, which is in Phase II clinical trials to evaluate the combination of ganetespib and paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer; and in Phase I/II trial in combination with the mTOR inhibitor sirolimus in patients with refractory sarcoma, including malignant peripheral nerve sheath tumors. The companys drug candidate in its Hsp90-inhibitor Drug Conjugate program is STA-12-8666, which is in preclinical trials for chemotherapy irinotecan. Synta Pharmaceuticals Corp. was incorporated in 2000 and is based in Lexington, Massachusetts.
- [By Lisa Levin]
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) shares were also up, gaining 61 percent to $0.393. Synta Pharmaceuticals announced plans to merge with privately-held Madrigal Pharmaceuticals.